As use of drugs like Ozempic and Zepbound rises, agencies have yet to find causa...
This week on "The Readout LOUD" podcast, live from #JPM24: A spate of deals and ...
In the latest edition of STAT's health tech newsletter: Accolade jumps on positi...
Canadian Health Minister Mark Holland says Florida's plan to import cheaper phar...
Housing, transportation and income constraints can impact patients’ health, and ...
The timeline for all those court cases about the future of Medicare’s drug price...
3M Health Care has received a $34.2m award to improve the treatment of traumatic...
GSK has gained approval from the China National Medical Products Administration ...
Myrobalan Therapeutics has secured $24m in a Series A funding round to develop C...
Oratrope is a small molecule commercialized by Lumos Pharma, with a leading Phas...
Though not approved in the US, Laboratoires Delbert’s extencilline will be the a...
Mirati filed a marketing authorisation application to the EMA for Krazati for pa...
Innovent has reported positive Phase III results for mazdutide, Eli Lilly’s next...
Expanded patient groups at risk of progression to severe Covid-19 will be eligib...
BridgeBio submitted the NDA with US FDA for the TTR stabiliser in December 2023 ...
Evotec has announced a collaboration with the Crohn's & Colitis Foundation to ad...
